Blood pressure re-screening for healthy adults: What is the best measure and interval

Journal of Human Hypertension

Volumn 26, Issue 9, 2012, Pages 540-546

  Takahashi, O ^a,b   Glasziou, P P ^a,c   Perera, R ^a   Shimbo, T ^d   Fukui, T ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c BOND UNIVERSITY   (Australia)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

blood pressure; cardiovascular disease; diagnostic tests; mass screening; primary prevention

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; JAPANESE; MALE; MASS SCREENING; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PULSE PRESSURE; SIGNAL NOISE RATIO; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE DETERMINATION; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84865277073     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2011.72     Document Type: Article

References (34)

1. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension 2009; 53: 480-486.
2. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52: 818-827.
3. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-2369.
4. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation 2008; 118: 2672-2678.
5. Okayama A, Kadowaki T, Okamura T, Hayakawa T, Ueshima H, NIPPON DATA80 Research Group. Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among Japanese men (NIPPON DATA80). J Hypertens 2006; 24: 459-462.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
7. Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziono JM, Manson JE et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension 2000; 36: 801-807.
8. Turnbull F, Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood-pressurelowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527-1535.
9. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-2544.
10. Del Mar C, Doust J, Glasziou P. Clinical Thinking; Evidence, Communication and Decision-Making 2006. Blackwell Publishing Ltd. BMJ Books: Oxford, U.K.
11. Glasziou PP, Aronson JK. Evidence-Based Medical Monitoring: From Principles to Practice 2008. Blackwell Publishing, BMJ books: Oxford.
12. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
13. U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2007; 147: 783-786.
14. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634-640.
15. Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ 2005; 330: 644-648.
16. Glasziou PP, Irwig L, Heritier S, Simes RJ, Tonkin A, LIPID Study Investigators. Monitoring cholesterol levels: measurement error or true change? Ann Intern Med 2008; 148: 656-661.
17. Bell KJ, Irwig L, Craig JC, Macaskill P. Use of randomised trials to decide when to monitor response to new treatment. BMJ 2008; 336: 361-365.
18. Bell KJ, Hayen A, Macaskill P, Craig JC, Neal BC, Irwig L. Mixed models showed no need for initial response monitoring after starting antihypertensive therapy. J Clin Epidemiol 2008; 62: 650-659.
19. Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, Vasan RS et al. Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation 2009; 119: 243-250.
20. Zheng L, Sun Z, Li J, Zhang R, Zhang X, Liu S et al. Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China. Stroke 2008; 39: 1932-1937.
21. Jones DW, Appel LJ, Sheps SG, Roccella EJ, Lenfant C. Measuring blood pressure accurately: new and persistent challenges. JAMA 2003; 289: 1027-1030.
22. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111: 697-716.
23. Stevens RJ, Oke J, Perera R. Statistical models for the control phase of clinical monitoring. Stat Methods Med Res 2010; 19: 394-414.
24. Shepard DS. Reliability of blood pressure measurements: implications for designing and evaluating programs to control hypertension. J Chronic Dis 1981; 34: 191-209.
25. Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008; 178: 1441-1449.
26. Bryan S, Saint-Pierre Larose M, Campbell N, Clarke J, Tremblay MS. Resting blood pressure and heart rate measurement in the Canadian Health Measures Survey, cycle 1. Health Rep 2010; 21: 71-78.
27. Klungel OH, de Boer A, Paes AH, Nagelkerke NJ, Seidell JC, Bakker A. Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. J Clin Epidemiol 2000; 53: 1158-1163.
28. Cook NR, Scherr PA, Evans DA, Laughlin LW, Chapman WG, Rosner B et al. Regression analysis of changes in blood pressure with oral contraceptive use. Am J Epidemiol 1985; 121: 530-540.
29. Rosner B, Polk BF. The implications of blood pressure variability for clinical and screening purposes. J Chronic Dis 1979; 32: 451-461.
30. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
31. Miura K, Soyama Y, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y et al. Comparison of four blood pressure indexes for the prediction of 10-year stroke risk in middle-aged and older Asians. Hypertension 2004; 44: 715-720.
32. Miura K, Dyer AR, Greenland P, Daviglus ML, Hill M, Liu K et al. Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study. Hypertension 2001; 38: 232-237.
33. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
34. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375: 938-948.